Enveric Biosciences
Phase 3Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. Leveraging its unique discovery and development platform, The Psybrary™, Enveric has created a robust Intellectual Property portfolio of novel molecules for specific mental health indications.
About
Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. Leveraging its unique discovery and development platform, The Psybrary™, Enveric has created a robust Intellectual Property portfolio of novel molecules for specific mental health indications.
Funding History
2Total raised: $9.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile